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Abstract
Background: The collection of individual-level pandemic (H1N1) 2009 influenza immunization data was considered 
important to facilitate optimal vaccine delivery and accurate assessment of vaccine coverage. These data are also 
critical for research aimed at evaluating the new vaccine's safety and effectiveness. Systems used to collect 
immunization data include manual approaches in which data are collected and retained on paper, electronic systems 
in which data are captured on computer at the point of vaccination and hybrid systems which are comprised of both 
computerized and manual data collection components. This study's objective was to compare the efficiencies and 
perceptions of data collection methods employed during Canada's pandemic (H1N1) 2009 influenza vaccination 
campaign.
Methods/Design: A pan-Canadian observational study was conducted in a convenience sample of public health 
clinics and healthcare institutions during the H1N1 vaccination campaign in the fall of 2009. The study design 
consisted of three stages: Stage 1 involved passive observation of the site's layout, processes and client flow; Stage 2 
entailed timing site staff on 20 clients through five core immunization tasks: i) client registration, ii) medical history 
collection, iii) medical history review, iv) vaccine administration record keeping and v) preparation of proof of vaccine 
administration for the client; in Stage 3, site staff completed a questionnaire regarding perceived usability of the site's 
data collection approach. Before the national study began, a pilot study was conducted in three seasonal influenza 
vaccination sites in Ontario, to both test that the proposed methodology was logistically feasible and to determine 
inter-rater reliability in the measurements of the research staff. Comparative analyses will be conducted across the 
range of data collection methods with respect to time required to collect immunization data, number and type of 
individual-level data elements collected, and clinic staff perceptions of the usability of the method employed at their 
site, using analysis of variance (ANOVA).
Discussion: Various data collection methods were employed at immunization sites across Canada during the 
pandemic (H1N1) 2009 influenza vaccination campaign. Our comparison of methods can facilitate planning an 
efficient, coordinated approach for collecting immunization data in future influenza seasons.
Background
Canada's preparation for an influenza pandemic included
the establishment of provincial/territorial infrastructure
to collect client data at the time of vaccination as well as
decisions on the data elements required for national
reporting of vaccination utilization. The efficient collec-
tion of client level data is vital to support optimal vaccine
delivery processes, timely assessment of vaccine coverage
and surveillance statistics at all population levels and the
completion of research to address important questions
including those regarding the new vaccine's safety and
effectiveness[1].
There are three distinct systems used to collect immu-
nization data: manual, electronic and hybrid. Manual
approaches utilize paper forms to collect client immuni-
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zation information at the point of care. While this is the
most simple and low-cost system, it precludes the imme-
diate availability of data. In the event that reporting on
vaccine coverage is required on a weekly basis, an
abstracter would need to manually audit the forms to
extract the necessary data. This extra step in the report-
ing process leads to less timely access and could intro-
duce considerable human error in the reported numbers.
The electronic approach consists of providers directly
entering client data into an electronic information system
at the point of care. The costs of such a system and the
staff training requirements are the two principle barriers
to this approach but the benefits of rapid and accurate
reporting of immunization events for decision-making,
evaluation and surveillance purposes are substantial.
Hybrid systems involve both paper and electronic meth-
ods, such as data collected on paper forms at the point of
vaccination and later manually entered into an electronic
repository where they are available for reporting. In set-
tings where resident registries are available, the use of
data linkages can expedite the input process.
Some Canadian health regions chose to collect pan-
demic (H1N1) 2009 influenza immunization data using
the same system implemented during the annual seasonal
influenza vaccination campaign while in other areas, new
methods were adopted. The use of a specific data collec-
t i o n  s y s t e m  b y  a  h e a l t h  r e g i o n  i s  t y p i c a l l y  b a s e d  o n
numerous factors including anticipated willingness to
adopt new technology as well as financial and human
resources. An influenza pandemic offers a unique oppor-
tunity to study the relative efficiency of these data collec-
tion processes across numerous settings all responding to
the same high profile health event. A time comparison of
immunization data collection methods would provide
invaluable information to healthcare decision-makers
who are reviewing their future plans after this recent pan-
demic as well as for public health authorities involved
with any mass vaccination campaign.
Time and motion studies involve an observer following
the movements and tasks of an individual and recording
the amount of time that is taken to complete the activity,
during a typical work shift. While observer-induced bias
can occur, it can be reduced by taking steps to reduce the
conspicuousness of the observer[2]. Studies are best car-
ried out in an environment that prevents the observer
from altering the task completion, but allows for accurate
data collection of the time spent completing each task.
While potentially expensive and time-consuming, time
and motion studies allow for the most accurate measure-
ment of structured components; therefore this design is
ideal for evaluating the efficiency of an immunization
visit which is typically comprised of standard, defined
tasks[3].
As members of the Public Health Agency of Canada/
Canadian Institutes for Health Research Influenza
Research Network (PCIRN)'s Vaccine Coverage Theme,
our mandate is to help address identified research gaps in
Canada's pandemic influenza preparedness initiative.
Our research is directed at identifying and evaluating
approaches to collecting pandemic vaccine delivery data
at the point of care (the theme's evaluation framework is
presented in Table 1). In this paper, we describe the pro-
tocol developed to meet the following objectives: i) to
observe how pandemic immunization data collection
methods affect a clinic's staffing requirements, equip-
ment requirements and immunization process; ii) to
measure the time spent by front-line immunization staff
(physicians, nurses, administrative support) to record cli-
ent data for pandemic immunization in public health
clinics and healthcare institutions using electronic,
paper-based or hybrid data collection systems and iii) to
identify the perceptions and attitudes of frontline pan-
demic (H1N1) 2009 influenza immunization staff toward
data collection methods employed at their sites.
Methods/Design
Study Design
The study was composed of a three-stage evaluation
comprised of passive clinic observation, a time and
motion study and survey methodology to assess data col-
lection approaches used in pandemic (H1N1) 2009 influ-
enza vaccination sites across Canada. Site visits occurred
between October and December 2009, during Canada's
pandemic vaccination campaign.
Site Inclusion Criteria
Participating clinics were public health sites or healthcare
institutions, selected to include representation from each
province and territory, as well as urban and rural settings.
However, given that the pandemic vaccine was only to be
offered in mass vaccination clinics for a finite amount of
time, we anticipated that all sites that agreed to partici-
pate would be selected as study sites and did not define a
specific sample size.
Recruitment
Email invitations were sent to Medical Officers of Health
of health regions and other provincial and regional health
authorities across Canada as well as local public health
department managers. The emails invited recipients to
have their health authority or clinic participate as a study
site, to propose alternate study sites under their jurisdic-
t i o n  t h a t  m a y  be  i n t e r e s t ed  i n  e n r o l l i n g,  o r  t o  r eq u e s t
more information regarding the study. Follow-up tele-
phone calls were also made. Once a site was recruited, the
site manager and research team decided on three specific
evaluation days for the visit. One study research associatePereira et al. BMC Medical Research Methodology 2010, 10:51
http://www.biomedcentral.com/1471-2288/10/51
Page 3 of 6
(RA) attended each study site for the three-day observa-
tion period. At the beginning of each of the three obser-
vation days, health region staff members had the
opportunity to ask the RA any questions about the study.
The primary inclusion criterion for participation in both
the time and motion and perception survey stages was
that the frontline staff member had to be involved with
the data-collection related aspects of an immunization
visit. Participating staff members also had to be proficient
in reading and writing in either English or French (all
study forms were available in both languages). Staff mem-
bers who wished to participate were asked to provide
written consent before they were observed and timed.
A notice was provided at all study sites, either on the
registration desk or posted at the site entrance, to notify
clients that the site was participating in a research study.
The notice also indicated that clients were under no obli-
gation to have an RA observe their visit and they could
verbally opt out without any consequence to their level of
care.
Stage 1 (Passive Clinic Observations) - On the initial
observation day at a site, the RA spent the first 1-2 hours
passively observing the clinic to become familiar with the
immunization processes as well as the specific core
immunization tasks that each staff member was responsi-
ble for at that site. It was expected that the following five
core tasks comprised the aspects of an immunization visit
where clinic staff members collected/recorded client
data:
(i) Client registration/check-in: client's demographic 
information (name, sex, date of birth, postal code, 
health number etc.) was collected
(ii) Medical history collection: client's risk status as 
well as history of chronic conditions and previous 
seasonal influenza vaccine administration was col-
lected
(iii) Medical history review: client's medical history 
was reviewed and additional information was 
recorded, as necessary
(iv) Vaccine administration record-keeping: after the 
vaccination, pertinent information regarding the 
administration (vaccine, dosage, dose number, lot 
number, vaccinator's name, site of vaccination etc.) 
was recorded
(v) Preparation of proof of vaccine administration for 
the client: a paper record was created indicating that 
the client had been vaccinated
During this clinic observation stage, the research team
noted the clinic layout and data collection processes used
for the core tasks and recorded any other general obser-
vations. The research team used the H1N1 Immunization
Clinic Data Collection Methods Observation Guide [4] to
steer the data collection (Additional File 1). The team also
identified the verbal/visual cues that denoted the start
and end of each task, in preparation for Stage 2, the time
and motion study. Examples of potential cues are defined
in Table 2, but differed depending on the clinic's layout
and processes. In cases where two or more tasks were
completed simultaneously, making it difficult to get accu-
Table 1: PCIRN Vaccine Coverage Theme - Evaluation 
Framework
Attribute Description of Measures
Simplicity Ease of operation for vaccine delivery and 
support staff to collect immunization data, 
and for decision makers and planners to 
obtain the information they need for 
monitoring purposes.
Flexibility Capacity to accommodate modifications 
to reflect changing requirements and local 
needs.
Data Quality Completeness (absence of missing data 
elements) and validity (absence of errors in 
the data) of the data recorded, and 
suitability of the data for satisfying 
reporting requirements. Suitability for 
research purposes.
Acceptability Willingness of persons and organizations 
to use the immunization data collection 
system, as well as feasibility of adoption.
Representativeness Accuracy in describing vaccine coverage 
over time and its distribution in the 
population by person and place (i.e., 
ensuring no exclusion of selected 
population subgroups or geographical 
areas).
Sensitivity Proportion of vaccine recipients captured 
in data collection system (since 
immunizations taking place across 
numerous settings may lead to incomplete 
data capture).
Timeliness Time required from act of immunization to 
generation of vaccine coverage estimates.
Stability Reliability (ability to collect, manage, and 
provide data properly without failure) and 
availability (ability to be operational when 
it is needed) of the immunization data 
collection system.
Security Presence of processes and mechanisms to 
protect the privacy and confidentiality of 
client information and to prevent data 
loss.Pereira et al. BMC Medical Research Methodology 2010, 10:51
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rate measurements of each task separately, total times for
these tasks were measured and recorded accordingly.
Days 2 and 3 began with the clinic observation stage for a
shorter duration, as the majority of data collected did not
vary from day to day at a location.
Stage 2 (Time and Motion Study) - The RA timed the
completion of each of the five core tasks by observing
consenting staff members who had a core task responsi-
bility. For example, when each of the five tasks was com-
pleted by a separate staff member, the RA observed five
staff members who complete these tasks and consented
to the study. Based on the layout of the clinic, the RA
tried to choose an unobtrusive location to observe the
staff member close enough to the interaction to see and/
or hear it take place (to record its duration) but at a great
enough distance to not interfere with the process. Start
and end times were based on both visual and verbal cues
which were recorded. For example, the "start time" of an
observation may have been the initial registration-related
task for a new client (i.e. began a new data form, engaged
the client in related conversation). "End time" was defined
as the point when the registration person had completed
all tasks associated with that specific client's registration.
The RA utilized a tablet computer and recorded observa-
tion times on an electronic Data Collection Form (which
included a time-stamp function that was used to time the
tasks). When the use of electronic devices was not feasi-
ble at a study site, the RA timed and recorded task com-
pletion using a stopwatch and paper forms, respectively.
For each of the three days, the RA observed and timed
the completion of 20 consecutive client interactions for
each of the five core tasks, where possible. Therefore, at
the end of the three evaluation days, there were 60 timed
measurements for each of the five tasks.
In order to optimize the probability that a "typical day"
was being captured by the measurements, and recogniz-
ing that there may be different levels of throughput at dif-
ferent times of the week, the RA attempted to attend the
immunization site on 3 different days of the week. The
RA  a l s o  t r i e d  t o  c o n d u c t  t h e  o b s e rv a t i o n s  a t  d i f f e r e n t
times on each of the three days, to account for time-based
differences in client-throughput as well as staffing. In
some instances, it was only possible for the RA to attend a
clinic for two days rather than three (due to logistical
issues or clinic schedules); therefore, on one of the two
days, the RA timed 40 observations per core task, rather
than 20, for a total of 60 observations per task over both
days. Additionally, when clinics did not operate at a single
location for more than one or two days, it was necessary
for the RA to conduct the three-day evaluation at multi-
ple sites within a single region.
Table 2: Examples of Start/End Cues for Immunization Tasks
Electronic Systems Paper/Hybrid Systems
Start Cue End Cue Start Cue End Cue
Task 1:
Client Registration
The client hands the 
health card to the 
registration staff member 
for swiping
The staff member stops 
confirming the 
demographic information 
that is entered into the 
system
The staff member begins 
asking the clients for 
demographic information
The staff members puts 




The staff member begins 
asking the client about risk 
status
The staff member direct 
the client to the 
vaccination area
The staff member begins 
asking the client about risk 
status
The staff member direct 




The client sits with the 
nurse at the vaccination 
area
The nurse appears to have 
stopped asking questions/
is no longer typing
The client sits with the 
nurse at the vaccination 
area
The nurse appears to have 
stopped asking questions/




Nurse checks off 
computerized form for 
record keeping
Nurse switches to next 
form
Nurse picks up pen to 
record details of the 
vaccination
Nurse puts his/her pen 
down
Task 5:
Preparation of Proof of 
Vaccine Administration for 
Client
Nurse types in proof of 
vaccine administration 
(name, date, vaccine 
name)
Nurse tells client the visit is 
complete
Nurse picks up pen to 
complete the proof form
Nurse hands the form to 
the clientPereira et al. BMC Medical Research Methodology 2010, 10:51
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Stage 3 (Staff Perception of Data Collection Methods) -
On each day, after observation of the 20 client interac-
tions per task, the observed staff member completed and
returned the Perceptions of Pandemic (H1N1) 2009
Influenza Data Collection Methods Questionnaire. This
Likert scale questionnaire was developed to elicit staff
user perceptions of the data collection method employed
at the study site (Additional File 2). On the anonymous
questionnaire, staff members were asked to provide
demographic information including any professional des-
ignation, role and the number of years they had used the
method employed at their site. On Day 1 only, observed
staff members were also asked to complete the Collected
Data Elements Questionnaire, to indicate which data ele-
ments they routinely collected from the client during
their core task (Additional File 3).
Pilot Study
A small pilot study was conducted in a convenience sam-
ple of three seasonal influenza vaccination clinics in
Ontario, immediately before the pandemic (H1N1) 2009
influenza vaccination campaign began across Canada.
The purposes of the pilot study were to test the proposed
methodology for the time and motion study (Stage 2), to
ensure that it was logistically feasible, to provide the
opportunity for any necessary modifications before the
full study began and to determine inter-rater reliability in
the measurements of the RAs who observed and timed
the immunization staff.
The RAs attended each pilot study site for a 1-day eval-
uation period during which they tested out study meth-
odology for each of the three stages, including the use of
all data collection forms. To pilot Stage 2, the RAs timed
the completion of each of the five core tasks by observing
staff members who had a core task responsibility. For
example, when each of the five tasks were completed by a
separate staff member, the RAs chose five staff members
who completed these tasks and independently observed
each one in turn over the course of the same client inter-
actions. For the purpose of this pilot study, each staff
member being observed was timed independently by the
RAs for three observations each. Following all three
observations of one staff member, the RAs compared
timing results. When the time duration for each observa-
tion varied by less than 5 seconds, the RAs continued on
to observe and time the next core task. If the variation
between two or more of the RAs' measurements was
greater than five seconds, the RAs discussed their timing
process in order to reach a consensus on the visual and
verbal cues they used to assume "start" and "end" times.
They then repeated the process for additional observa-
tions, until the durations were within five seconds of each
other . A t this point, the RAs observed a staff member
who was completing the next core task. The threshold of
five seconds was chosen as a sufficiently short duration to
ensure adequate reliability, given that immunization tasks
could potentially be completed fairly quickly. To assess
inter-rater reliability the intraclass correlation coefficient
was calculated for each task in four of the six raters. Bland
and Altman plots were constructed for each task to assess
agreement between the raters with the maximum and
minimum times.
At completion, the research team noted any changes to
their timing process and to the data collection forms that
were required for the full study in order to ensure satis-
factory study flow as well as minimal disruption to the
immunization process.
Data Management
All data were collected using standardized paper or elec-
tronic data forms and transferred into a shared Microsoft
Excel 2007 file at the end of each site visit. This file is
password-protected and can only be accessed by mem-
bers of the research team. Collation and data analysis is
being carried out by the research team at the Ontario
Agency for Health Protection and Promotion, Ontario.
Statistical Analysis
Stage 1 (Clinic Observations): The results of the clinic
observation component will be analyzed descriptively,
and compared across data collection methods.
Stage 2 (Time and Motion Study): Based on the above
methodology, it is expected that observation time will be
calculated for each separate component of the vaccina-
tion process. However, in the event that two or more
tasks were completed simultaneously, making it difficult
to distinguish time per task, a total vaccination time will
be  d et e rm i n ed  f o r  c l i e n ts,  c o n s t i t u t i n g  a  s u m  o f  t h o se
tasks. The mean observation time per task across all sites
pe r da ta c oll ect io n m et hod wil l be  cal cula t ed.  A v er a ge
times will be compared across data collection methods
using an analysis of variance (ANOVA) test. The outcome
will be assessed for parametric assumptions, and if these
are not met, the Median test, the Kruskal-Wallis H test,
and the Mann-Whitney U test will be used. Covariates to
be investigated in the model include client throughput,
clinic population, location, vaccination week, RA and
staff member. Clinic times and percentage of data collec-
tion elements collected will be compared across type of
study site by data collection method. Statistical models
will be fit using SAS version 8.1 statistical software (Cary,
North Carolina) per core task, as well as in total across all
five tasks.
Stage 3 (Staff Perception of Data Collection Methods):
Univariate ANOVA will be used to compare responses
based on data collection method. Should a statistically
significant result be obtained (p < 0.05), Tukey's pairwise
comparison will be used to determine where the differ-
ences existed. Responses will also be analyzed and sum-
marized by type of study site. Clinic times and percentagePereira et al. BMC Medical Research Methodology 2010, 10:51
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of data collection elements collected (from full set in
Additional File 3) will be compared across type of study
site by data collection method.
Ethical Considerations
This project has ethics approval from the University of
Toronto Research Ethics Board. When potential sites
required additional approval from their own ethics board
before participating, this was sought if an expedited
review was available. If REB approval could not be
obtained before the end of the pandemic vaccination
campaign in that region, the site was not able to partici-
pate. No identifying clinic staff or client information was
collected during this study.
Discussion
We report the protocol of a study that was developed to
compare the different approaches that were used to col-
lect pandemic (H1N1) 2009 influenza immunization data
across Canada. To our knowledge, this is the first study to
compare electronic, hybrid and paper-based immuniza-
tion data collection systems based on the outcome mea-
sures of time and user perception.
Public health regions can vary tremendously in terms of
population size, demographics, health status and other
characteristics and it cannot be expected that a single
immunization data collection system will be optimal
a c r o s s  t h e s e  r e g i o n s .  T h i s  s t u d y  i s  b a s e d  o n  a  c o n v e -
nience sample of health regions which may limit its repre-
sentativeness and generalizability. However, we
attempted to recruit a cross-section of different health
regions. At the completion of data analyses, each partici-
pating health region will receive feedback on their clinic's
performance, relative to other similar health regions. A
broader report, comparing manual, electronic and hybrid
systems of influenza immunization data collection but
not specifically identifying participating sites or prov-
inces will be disseminated to share findings with all pub-
lic health jurisdictions.
Comparing data collection approaches at immuniza-
tion clinics across the country using time and motion
studies is an appropriate way of evaluating the efficiency
of such methods, which will provide valuable information
to pandemic planners and public health authorities plan-
ning mass immunization responses. Additionally, results
of this study will guide public health decision-makers at
all government levels to improve planning while conduct-
ing mass immunization campaigns and when creating
new data collection methods or modifying current pro-




ANOVA: Analysis of Variance; RA: Research Associate.
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